Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
Simon J.A. et al.
Editor's note
The 52-week open-label extension to RECONNECT. Tolerability stays bumpy — nausea, flushing, transient blood-pressure rises — but the women who continued kept the desire and distress gains. The longest-duration PT-141 dataset that exists in humans.